Clinical Trial Update: Quality of Life During Treatment of Chronic Hepatitis C (P05278/MK-4031-336)

View source ↗

Summary

This clinical trial update reports patient-reported quality of life outcomes during treatment for chronic hepatitis C genotype 1, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• MK-4031-336

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C, Chronic, Genotype 1 | Status: COMPLETED | Results posted: 2014-06-12